SG11201503670YA - Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1 - Google Patents
Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1Info
- Publication number
- SG11201503670YA SG11201503670YA SG11201503670YA SG11201503670YA SG11201503670YA SG 11201503670Y A SG11201503670Y A SG 11201503670YA SG 11201503670Y A SG11201503670Y A SG 11201503670YA SG 11201503670Y A SG11201503670Y A SG 11201503670YA SG 11201503670Y A SG11201503670Y A SG 11201503670YA
- Authority
- SG
- Singapore
- Prior art keywords
- adp
- ribose
- polymerase
- poly
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3742MU2012 | 2012-12-31 | ||
PCT/IN2013/000794 WO2014102817A1 (fr) | 2012-12-31 | 2013-12-23 | Dérivés substitués de phtalazin-1(2h)-one comme inhibiteurs sélectifs de la poly(adp-ribose) polymérase-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201503670YA true SG11201503670YA (en) | 2015-07-30 |
Family
ID=54198806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201503670YA SG11201503670YA (en) | 2012-12-31 | 2013-12-23 | Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1 |
Country Status (30)
Country | Link |
---|---|
US (1) | US9598418B2 (fr) |
EP (1) | EP2938598B1 (fr) |
JP (1) | JP5930452B2 (fr) |
KR (1) | KR101652654B1 (fr) |
CN (1) | CN104918917A (fr) |
AP (1) | AP2015008439A0 (fr) |
AR (1) | AR094299A1 (fr) |
AU (1) | AU2013368842B2 (fr) |
BR (1) | BR112015012425A2 (fr) |
CA (1) | CA2890309A1 (fr) |
CL (1) | CL2015001655A1 (fr) |
CO (1) | CO7400872A2 (fr) |
DK (1) | DK2938598T3 (fr) |
EA (1) | EA201591239A1 (fr) |
ES (1) | ES2614885T3 (fr) |
GE (1) | GEP201706691B (fr) |
HK (1) | HK1210466A1 (fr) |
HR (1) | HRP20170219T1 (fr) |
HU (1) | HUE030613T2 (fr) |
IL (1) | IL238714A0 (fr) |
MA (1) | MA38080A1 (fr) |
MX (1) | MX2015006780A (fr) |
NZ (1) | NZ708255A (fr) |
PH (1) | PH12015501199B1 (fr) |
PL (1) | PL2938598T3 (fr) |
PT (1) | PT2938598T (fr) |
SG (1) | SG11201503670YA (fr) |
TW (1) | TWI553005B (fr) |
WO (1) | WO2014102817A1 (fr) |
ZA (1) | ZA201503218B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
CN105764905B (zh) | 2013-11-26 | 2019-06-07 | 豪夫迈·罗氏有限公司 | 新的八氢-环丁二烯并[1,2-c;3,4-c’]二吡咯-2基 |
PL3122750T3 (pl) | 2014-03-26 | 2020-03-31 | F.Hoffmann-La Roche Ag | Związki bicykliczne jako inhibitory wytwarzania autotaksyny (ATX) i kwasu lizofosfatydowego (LPA) |
US10562886B2 (en) | 2015-05-21 | 2020-02-18 | The Regents Of The University Of California | Anti-cancer compounds |
MX2018000511A (es) | 2015-09-04 | 2018-04-24 | Hoffmann La Roche | Derivados de fenoximetilo. |
CR20180143A (es) | 2015-09-24 | 2018-05-03 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca |
EP3353180B1 (fr) | 2015-09-24 | 2022-03-16 | F. Hoffmann-La Roche AG | Composes bicycliques utiles comme inhibiteurs atx |
AU2016328437A1 (en) * | 2015-09-24 | 2018-01-25 | F. Hoffmann-La Roche Ag | Bicyclic compounds as ATX inhibitors |
MA42923A (fr) * | 2015-09-24 | 2021-04-28 | Hoffmann La Roche | Composés bicycliques comme inhibiteurs mixtes de atx/ca |
CN107428762B (zh) * | 2015-10-30 | 2020-03-10 | 四川科伦博泰生物医药股份有限公司 | 酞嗪酮衍生物、其制备方法及用途 |
WO2017101796A1 (fr) * | 2015-12-16 | 2017-06-22 | 四川科伦博泰生物医药股份有限公司 | Dérivé de phtalazinone, et procédé de préparation et utilisation associés |
ES2964531T3 (es) * | 2016-06-24 | 2024-04-08 | Univ California | Derivados de ftalazina como inhibidores de PARP1, PARP2 y/o tubulina útiles para el tratamiento del cáncer |
JP7090099B2 (ja) | 2017-03-16 | 2022-06-23 | エフ.ホフマン-ラ ロシュ アーゲー | Atxインヒビターとしての新規二環式化合物 |
CA3053329A1 (fr) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | Composes heterocycliques utiles en tant qu'inhibiteurs doubles d'atx/ca |
RS60209B1 (sr) | 2017-03-20 | 2020-06-30 | Forma Therapeutics Inc | Kompozicije pirolopirola kao aktivatori piruvat kinaze (pkr) |
CN109251204A (zh) * | 2017-07-13 | 2019-01-22 | 中国药科大学 | 含有酞嗪-1(2h)-酮结构的parp抑制剂、其制法及医药用途 |
CN108164468B (zh) * | 2018-02-09 | 2021-02-02 | 上海卫岑医药科技有限公司 | 一种parp抑制剂、其药物组合物、制备方法及应用 |
WO2020061255A1 (fr) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Activation de la pyruvate kinase r |
US20220031671A1 (en) | 2018-09-19 | 2022-02-03 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
WO2021225407A1 (fr) * | 2020-05-08 | 2021-11-11 | 주식회사 티씨노바이오사이언스 | Nouveau dérivé de phtalazine ayant une activité d'inhibition de l'ectonucléotide pyrophosphatase/phosphodiestérase, et son utilisation |
US20240208912A1 (en) * | 2021-03-11 | 2024-06-27 | Mirati Therapeutics, Inc. | MTA-Cooperative PRMT5 Inhibitors |
WO2023288002A1 (fr) * | 2021-07-16 | 2023-01-19 | Oregon Health & Science University | Inhibiteurs de parp-1 à base de phtalazinone |
WO2023174250A1 (fr) * | 2022-03-15 | 2023-09-21 | Beigene , Ltd. | Dérivés de 4-(aminométhyl)-6-(1-méthyl-1h-pyrazol-4-yl) isoquinolin-1(2h)-one utilisés comme inhibiteurs de la prmt5 coopérant avec la mta |
WO2024046420A1 (fr) * | 2022-08-31 | 2024-03-07 | 江苏恒瑞医药股份有限公司 | Composé bicyclique fusionné, son procédé de préparation et son utilisation en médecine |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6531464B1 (en) | 1999-12-07 | 2003-03-11 | Inotek Pharmaceutical Corporation | Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives |
EP1330442B1 (fr) | 2000-10-30 | 2011-01-19 | Kudos Pharmaceuticals Limited | Derives de phtalazinone |
US7449464B2 (en) * | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
PL1633724T3 (pl) | 2003-03-12 | 2011-10-31 | Kudos Pharm Ltd | Pochodne ftalazynonu |
CN100584840C (zh) | 2004-01-05 | 2010-01-27 | 阿斯利康(瑞典)有限公司 | 取代杂环化合物及其应用 |
JP2008510783A (ja) | 2004-08-26 | 2008-04-10 | クドス ファーマシューティカルズ リミテッド | 4−ヘテロアリールメチル置換フタラジノン誘導体 |
WO2006039545A2 (fr) | 2004-09-30 | 2006-04-13 | Maxim Pharmaceuticals, Inc. | Utilisation d'inhibiteurs parp-1 permettant de proteger des lymphocytes tumoricides contre l'apoptose |
JP2008534664A (ja) | 2005-04-06 | 2008-08-28 | アストラゼネカ アクチボラグ | 置換複素環およびchk1、pdk1及びpak阻害剤としてのそれらの使用 |
WO2007062413A2 (fr) | 2005-11-25 | 2007-05-31 | University Of Medicine And Dentistry Of New Jersey | Utilisation d'inhibiteurs du parp-1 |
GB0610680D0 (en) * | 2006-05-31 | 2006-07-12 | Istituto Di Ricerche D Biolog | Therapeutic compounds |
TWI404716B (zh) | 2006-10-17 | 2013-08-11 | Kudos Pharm Ltd | 酞嗪酮(phthalazinone)衍生物 |
US8466150B2 (en) * | 2006-12-28 | 2013-06-18 | Abbott Laboratories | Inhibitors of poly(ADP-ribose)polymerase |
CN103690542B (zh) * | 2006-12-28 | 2015-11-18 | Abbvie公司 | 聚(adp-核糖)聚合酶抑制剂 |
CA2687786A1 (fr) | 2007-05-25 | 2008-12-04 | Astrazenca Ab | Combinaison d'inhibiteurs de chk et de parp dans le traitement du cancer |
US20090023727A1 (en) * | 2007-07-05 | 2009-01-22 | Muhammad Hashim Javaid | Phthalazinone derivatives |
AU2008322676B9 (en) * | 2007-11-15 | 2014-03-27 | Msd Italia S.R.L. | Pyridazinone derivatives as PARP inhibitors |
UY31603A1 (es) | 2008-01-23 | 2009-08-31 | Derivados de ftalazinona | |
EP2346495B2 (fr) | 2008-10-07 | 2023-05-24 | Kudos Pharmaceuticals Limited | Formulation pharmaceutique 514 |
EP2598491B1 (fr) | 2010-07-27 | 2015-09-02 | Cadila Healthcare Limited | Dérivés substitués de 4-(4-fluoro-3-(pipérazine-1- carbonyl)benzyl)phtalazin-1(2h)-one en tant qu'inhibiteur de la poly(adp-ribose) polymérase-1 |
CN102372716A (zh) | 2010-08-09 | 2012-03-14 | 江苏恒瑞医药股份有限公司 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
CN102372706A (zh) * | 2010-08-09 | 2012-03-14 | 江苏恒瑞医药股份有限公司 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
CN102372698A (zh) * | 2010-08-10 | 2012-03-14 | 江苏恒瑞医药股份有限公司 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
US8999985B2 (en) * | 2010-12-02 | 2015-04-07 | Shanghai De Novo Pharmatech Co Ltd. | Substituted phthalazin-1(2H)-ones, preparation processes and medical uses thereof |
CN102485721B (zh) | 2010-12-03 | 2015-12-09 | 曹亚 | 取代的2,3-二氮杂萘酮化合物及其用途 |
EP2714703B1 (fr) | 2011-05-31 | 2021-03-10 | Newgen Therapeutics, Inc. | Inhibiteurs tricycliques de poly(adp-ribose)polymérase |
CN103703002B (zh) | 2011-07-13 | 2016-05-11 | 参天制药株式会社 | 具有parp抑制活性的新型化合物 |
US20130053365A1 (en) | 2011-08-30 | 2013-02-28 | Biomarin Pharmaceutical, Inc. | Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
EP2797919B1 (fr) | 2011-12-31 | 2017-03-29 | BeiGene, Ltd. | Pyridophthalazinones tétra ou pentacycliques fusionnés à utiliser en tant qu'inhibiteurs de parp |
CN103242273B (zh) | 2012-02-09 | 2015-06-03 | 中国科学院上海药物研究所 | 2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途 |
SG11201404654SA (en) | 2012-02-09 | 2014-09-26 | Merck Patent Gmbh | Tetrahydro-quinazolinone derivatives as tank and parp inhibitors |
-
2013
- 2013-12-23 BR BR112015012425A patent/BR112015012425A2/pt not_active IP Right Cessation
- 2013-12-23 KR KR1020157017355A patent/KR101652654B1/ko active IP Right Grant
- 2013-12-23 MX MX2015006780A patent/MX2015006780A/es unknown
- 2013-12-23 GE GEAP201313901A patent/GEP201706691B/en unknown
- 2013-12-23 CA CA2890309A patent/CA2890309A1/fr not_active Abandoned
- 2013-12-23 DK DK13828996.2T patent/DK2938598T3/en active
- 2013-12-23 HU HUE13828996A patent/HUE030613T2/en unknown
- 2013-12-23 PL PL13828996T patent/PL2938598T3/pl unknown
- 2013-12-23 CN CN201380069025.0A patent/CN104918917A/zh active Pending
- 2013-12-23 EA EA201591239A patent/EA201591239A1/ru unknown
- 2013-12-23 US US14/647,088 patent/US9598418B2/en not_active Expired - Fee Related
- 2013-12-23 PT PT138289962T patent/PT2938598T/pt unknown
- 2013-12-23 AP AP2015008439A patent/AP2015008439A0/xx unknown
- 2013-12-23 WO PCT/IN2013/000794 patent/WO2014102817A1/fr active Application Filing
- 2013-12-23 ES ES13828996.2T patent/ES2614885T3/es active Active
- 2013-12-23 MA MA38080A patent/MA38080A1/fr unknown
- 2013-12-23 EP EP13828996.2A patent/EP2938598B1/fr not_active Not-in-force
- 2013-12-23 NZ NZ708255A patent/NZ708255A/en not_active IP Right Cessation
- 2013-12-23 JP JP2015550210A patent/JP5930452B2/ja not_active Expired - Fee Related
- 2013-12-23 AU AU2013368842A patent/AU2013368842B2/en not_active Ceased
- 2013-12-23 SG SG11201503670YA patent/SG11201503670YA/en unknown
- 2013-12-26 TW TW102148473A patent/TWI553005B/zh not_active IP Right Cessation
- 2013-12-27 AR ARP130105054A patent/AR094299A1/es unknown
-
2015
- 2015-05-08 ZA ZA2015/03218A patent/ZA201503218B/en unknown
- 2015-05-10 IL IL238714A patent/IL238714A0/en not_active IP Right Cessation
- 2015-05-28 PH PH12015501199A patent/PH12015501199B1/en unknown
- 2015-06-03 CO CO15127891A patent/CO7400872A2/es unknown
- 2015-06-12 CL CL2015001655A patent/CL2015001655A1/es unknown
- 2015-11-13 HK HK15111208.8A patent/HK1210466A1/xx not_active IP Right Cessation
-
2017
- 2017-02-09 HR HRP20170219TT patent/HRP20170219T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20170219T1 (hr) | Supstituirani derivati ftalazin-1(2h)-ona kao selektivni inhibitori poli(adp-riboza)polimeraze-1 | |
HRP20181429T1 (hr) | Novi derivati benzimidazola kao inhibitori kinaze | |
HK1216645A1 (zh) | 大環噠嗪酮衍生物 | |
ZA201406078B (en) | Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhibitors | |
SI2857404T1 (sl) | Imidazo(1,2-b)piridazin derivati kot kinazni inhibitorji | |
HK1216147A1 (zh) | 取代的苯甲酰基 -氟- -亞氨基- -甲基- -二氫嘧啶- -酮衍生物 | |
IL238693A0 (en) | Tricyclic benzamidazoles are converted as kinase inhibitors | |
ZA201303614B (en) | Quinazolin-4(3h)-one derivatives used as p13 kinase inhibitors | |
HK1214475A1 (zh) | 經取代的 -氟- -亞胺基- -甲基- -側氧基- -二氫嘧啶- -甲酸酯衍生物 | |
HK1203961A1 (en) | Bicyclic pyrazinone derivatives | |
HK1222396A1 (zh) | 作為選擇性蛋白質激酶抑制劑之苯並咪唑衍生物 | |
GB2521802B (en) | Reissue of crypographic credentials | |
HK1200166A1 (en) | 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors parp-1 3---1(2h)- |